Egg-derived tri-peptide IRW exerts antihypertensive effects in spontaneously hypertensive rats

PLoS ONE

Volumn 8, Issue 11, 2013, Pages

  Majumder, Kaustav ^a   Chakrabarti, Subhadeep ^a   Morton, Jude S ^a   Panahi, Sareh ^a   Kaufman, Susan ^a   Davidge, Sandra T ^a   Wu, Jianping ^a  

^a UNIVERSITY OF ALBERTA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN II; ANTIHYPERTENSIVE AGENT; DIPEPTIDYL CARBOXYPEPTIDASE; EGG WHITE; ISOLEUCYLARGINYLTRYPTOPHAN; NITRIC OXIDE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIHYPERTENSIVE ACTIVITY; ARTICLE; BLOOD PRESSURE MEASUREMENT; CIRCADIAN RHYTHM; CONTROLLED STUDY; DRUG MEGADOSE; ENZYME INHIBITION; HEART RATE; HUMAN; HUMAN CELL; HYPERTENSION; IN VIVO STUDY; INFLAMMATION; LOW DRUG DOSE; MALE; NONHUMAN; OXIDATIVE STRESS; PROTEIN BLOOD LEVEL; RAT; SPONTANEOUSLY HYPERTENSIVE RAT; TELEMETRY; VASODILATATION;

ANIMALS; ANTIHYPERTENSIVE AGENTS; BLOOD VESSELS; BLOTTING, WESTERN; CIRCADIAN RHYTHM; EGG WHITE; FLUORESCENT ANTIBODY TECHNIQUE; HYPERTENSION; MALE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE TYPE III; NITROSATION; OLIGOPEPTIDES; OXIDATIVE STRESS; RATS; RATS, INBRED SHR; TELEMETRY;

EID: 84896691651     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0082829     Document Type: Article

References (57)

1. World Health Organisation (WHO) (2012). Global Atlas on Cardiovascular Disease Prevention and Control. 2013
2. Chockalingam A (2008) World hypertension day and global awareness. Can J Cardiol 24: 441-444. doi:10.1016/S0828-282X(08)70617-2. PubMed: 18548140.
3. do Pinho Franco Carmo, M, Nigro D, Fortes ZB, Tostes RC, Carvalho MH et al. (2003) Intrauterine undernutrition - renal and vascular origin of hypertension. Cardiovasc Res 60: 228-234. doi:10.1016/S0008-6363(03)00541-8. PubMed: 14613851. Available online at: doi: 10.1016/S0008-6363(03)00541-8 Available online at: PubMed: 14613851
4. Feihl F, Liaudet L, Levy BI, Waeber B (2008) Hypertension and microvascular remodelling. Cardiovasc Res 78: 274-285. doi: 10.1093/cvr/cvn022. PubMed: 18250145. (Pubitemid 351556101)
5. Sriramula S, Cardinale JP, Lazartigues E, Francis J (2011) ACE2 overexpression in the paraventricular nucleus attenuates angiotensin II-induced hypertension. Cardiovasc Res 92: 401-408. doi:10.1093/cvr/cvr242. PubMed: 21952934.
6. Paravicini TM, Touyz RM (2006) Redox signaling in hypertension. Cardiovasc Res 71: 247-258. doi:10.1016/j.cardiores.2006.05.001. PubMed: 16765337.
7. Koh KK, Oh PC, Quon MJ (2009) Does reversal of oxidative stress and inflammation provide vascular protection? Cardiovasc Res 81: 649-659. PubMed: 19098298.
8. Moser M, Franklin SS (2007) Hypertension management: Results of a new national survey for the hypertension education foundation: Harris interactive. J Clin Hypertens (Greenwich) 9: 316-323. doi:10.1111/j.1524-6175.2007.07152.x. PubMed: 17485966.
9. Brown MJ (2006) Hypertension and ethnic group. BMJ 332: 833-836. doi:10.1136/bmj.332.7545.833. PubMed: 16601044.
10. Khanna A, Lefkowitz L, White WB (2008) Evaluation of recent fixeddose combination therapies in the management of hypertension. Curr Opin Nephrol Hypertens 17: 477-483. doi:10.1097/MNH.0b013e3283069d72. PubMed: 18695388.
11. Atkinson AB, Robertson JIS (1979) Captopril in the treatment of clinical hypertension and cardiac-failure. Lancet 2: 836-839. PubMed: 90928.
12. Torruco-Uco JG, Dominguez-Magana MA, Davila-Ortiz G, Martinez-Ayala A, Chel-Guerrero LA et al. (2008) Antihypertensive peptides, an alternative for treatment of natural origin: A review. Ciencia y Tecnologia Alimentaria 6: 158-168. doi:10.1080/11358120809487641.
13. Martínez-Maqueda D, Miralles B, Recio I, Hernández-Ledesma B (2012) Antihypertensive peptides from food proteins: A review. Food Funct 3: 350-361. PubMed: 22249830.
14. Korhonen H, Pihlanto A (2003) Food-derived bioactive peptides - opportunities for designing future foods. Curr Pharm Des 9: 1297-1308. doi:10.2174/1381612033454892. PubMed: 12769738. (Pubitemid 36592138)
15. Meisel H (2004) Multifunctional peptides encrypted in milk proteins. Biofactors 21: 55-61. doi:10.1002/biof.552210111. PubMed: 15630170.
16. Yoshikawa M, Fujita H, Matoba N, Takenaka Y, Yamamoto T et al. (2000) Bioactive peptides derived from food proteins preventing lifestyle-related diseases. Biofactors 12: 143-146. doi:10.1002/biof.5520120122. PubMed: 11216476. (Pubitemid 32107398)
17. Majumder K, Wu J (2010) A new approach for identification of novel antihypertensive peptides from egg proteins by QSAR and bioinformatics. Food Research International 43: 1371-1378. doi: 10.1016/j.foodres.2010.04.027.
18. Huang W, Chakrabarti S, Majumder K, Jiang Y, Davidge ST et al. (2010) Egg-derived peptide IRW inhibits TNF-α-induced inflammatory response and oxidative stress in endothelial cells. J Agric Food Chem 58: 10840-10846. doi:10.1021/jf102120c.
19. Majumder K, Chakrabarti S, Davidge ST, Wu J (2013) Structure and activity study of egg protein ovotransferrin derived peptides (IRW and IQW) on endothelial inflammatory response and oxidative stress. J Agric Food Chem: ([MedlinePgn:]) PubMed: 23317476.
20. Trippodo NC, Frohlich ED (1981) Similarities of genetic (spontaneous) hypertension. man and rat. Circ Res 48: 309-319. doi:10.1161/01.RES.48.3.309. PubMed: 7460205. (Pubitemid 11102692)
21. Zicha J, Kunes J (1999) Ontogenetic aspects of hypertension development: Analysis in the rat. Physiol Rev 79: 1227-1282. PubMed: 10508234. (Pubitemid 29473316)
22. Reaves PY, Beck CR, Wang HW, Raizada MK, Katovich MJ (2003) Endothelial-independent prevention of high blood pressure in L-NAME-treated rats by angiotensin II type I receptor antisense gene therapy. Exp Physiol 88: 467-473. doi:10.1113/eph8802579. PubMed: 12861333. (Pubitemid 36874681)
23. Liu KL (2009) Regulation of renal medullary circulation by the reninangiotensin system in genetically hypertensive rats. Clin Exp Pharmacol Physiol 36: 455-461. doi:10.1111/j.1440-1681.2009.05153.x. PubMed: 19215237.
24. Wu L, Juurlink BH (2002) Increased methylglyoxal and oxidative stress in hypertensive rat vascular smooth muscle cells. Hypertension 39: 809-814. doi:10.1161/hy0302.105207. PubMed: 11897769. (Pubitemid 34252881)
25. Hultström M (2012) Development of structural kidney damage in spontaneously hypertensive rats. J Hypertens 30: 1087-1091. doi: 10.1097/HJH.0b013e328352b89a. PubMed: 22469837.
26. Dornas WC, Silva ME (2011) Animal models for the study of arterial hypertension. J Biosci 36: 731-737. doi:10.1007/s12038-011-9097-y. PubMed: 21857120.
27. Iroyukifujita H, Eiichiyokoyama K, Yoshikawa Masaaki (2000) Classification and antihypertensive activity of angiotensin I-converting enzyme inhibitory peptides derived from food proteins. 65
28. Sipola M, Finckenberg P, Santisteban J, Korpela R, Vapaatalo H et al. (2001) Long-term intake of milk peptides attenuates development of hypertension in spontaneously hypertensive rats. J Physiol Pharmacol 52: 745-754. PubMed: 11785770. (Pubitemid 34042359)
29. Fujita H, Yoshikawa M (1999) LKPNM: A prodrug-type ACE-inhibitory peptide derived from fish protein. Immunopharmacology 44: 123-127. doi:10.1016/S0162- 3109(99)00118-6. PubMed: 10604535.
30. Schwartz GJ, Salorio CF, Skoglund C, Moran TH (1999) Gut vagal afferent lesions increase meal size but do not block gastric preload-induced feeding suppression. Am J Physiol 276: R1623-R1629. PubMed: 10362740. (Pubitemid 29323525)
31. Alcendor DJ, Charest AM, Zhu WQ, Vigil HE, Knobel SM (2012) Infection and upregulation of proinflammatory cytokines in human brain vascular pericytes by human cytomegalovirus. J Neuroinflammation 9: 95-2094-9-95. PubMed: 22607552.
32. Arenas IA, Xu Y, Lopez-Jaramillo P, Davidge ST (2004) Angiotensin II-induced MMP-2 release from endothelial cells is mediated by TNF-alpha. Am J Physiol Cell Physiol 286: C779-C784. doi:10.1152/ajpcell.00398.2003. PubMed: 14644777. (Pubitemid 38543805)
33. Chakrabarti S, Davidge ST (2009) High glucose-induced oxidative stress alters estrogen effects on ERalpha and ERbeta in human endothelial cells: Reversal by AMPK activator. J Steroid Biochem Mol Biol 117: 99-106. doi:10.1016/j.jsbmb.2009.07.007. PubMed: 19635557.
34. Merchant SJ, Narumiya H, Zhang Y, Guilbert LJ, Davidge ST (2004) The effects of preeclampsia and oxygen environment on endothelial release of matrix metalloproteinase-2. Hypertens Pregnancy 23: 47-60. doi:10.1081/PRG-120028281. PubMed: 15117600. (Pubitemid 38445552)
35. Morton JS, Rueda-Clausen CF, Davidge ST (2010) Mechanisms of endothelium-dependent vasodilation in male and female, young and aged offspring born growth restricted. Am J Physiol Regul Integr Comp Physiol 298: R930-R938. doi:10.1152/ajpregu.00641.2009. PubMed: 20053962.
36. Dávalos A, Miguel M, Bartolomé B, López- Fandiño R (2004) Antioxidant activity of peptides derived from egg white proteins by enzymatic hydrolysis. J Food Prot 67: 1939-1944. PubMed: 15453585.
37. Theuwissen E, Mensink RP (2007) Simultaneous intake of beta-glucan and plant stanol esters affects lipid metabolism in slightly hypercholesterolemic subjects. J Nutr 137: 583-588. PubMed: 17311944. (Pubitemid 46397487)
38. Aleixandre A, Miguel M, Muguerza B (2008) Peptides with antihypertensive activity obtained from milk and egg proteins. Nutricion Hospitalaria 23: 313-318. PubMed: 18604316. (Pubitemid 352030201)
39. Cheung IWY, Nakayama S, Hsu MNK, Samaranayaka AGP, Li-Chan ECY (2009) Angiotensin-I converting enzyme inhibitory activity of hydrolysates from oat (avena sativa) proteins by in silico and in vitro analyses. J Agric Food Chem 57: 9234-9242. doi:10.1021/jf9018245. PubMed: 19731915.
40. Miguel M, Aleixandre A (2006) Anti hypertensive peptides derived from egg proteins. J Nutr 136: 1457-1460. PubMed: 16702303. (Pubitemid 43765344)
41. Huang W, Majumder K, Wu J (2010) Oxygen radical absorbance capacity of peptides from egg white protein ovotransferrin and their interaction with phytochemicals. Food Chem 123: 635-641. doi: 10.1016/j.foodchem.2010.04.083.
42. Hasler CM (2000) The changing face of functional foods. J Am Coll Nutr 19: 499S-506S. doi:10.1080/07315724.2000.10718972. PubMed: 11022999.
43. Henry R, Casto R, Printz MP (1990) Diurnal cardiovascular patterns in spontaneously hypertensive and wistar-kyoto rats. Hypertension 16: 422-428. doi:10.1161/01.HYP.16.4.422. PubMed: 2210810. (Pubitemid 20338536)
44. Lemmer B, Mattes A, Böhm M, Ganten D (1993) Circadian blood pressure variation in transgenic hypertensive rats. Hypertension 22: 97-101. doi:10.1161/01.HYP.22.1.97. PubMed: 8319999. (Pubitemid 23187390)
45. Portaluppi F, Tiseo R, Smolensky MH, Hermida RC, Ayala DE et al. (2012) Circadian rhythms and cardiovascular health. Sleep Med Rev 16: 151-166. doi:10.1016/j.smrv.2011.04.003. PubMed: 21641838.
46. Shimamura T, Nakajima M, Iwasaki T, Hayasaki Y, Yonetani Y et al. (1999) Analysis of circadian blood pressure rhythm and target-organ damage in stroke-prone spontaneously hypertensive rats. J Hypertens 17: 211-220. doi:10.1097/00004872-199917020-00005. PubMed: 10067790. (Pubitemid 29074109)
47. Coca A (1994) Circadian-rhythm and blood-pressure control - physiological and pathophysiological factors. J Hypertens 12: S13-S21. doi:10.1097/00004872- 199404000-00022.
48. Kietadisorn R, Juni RP, Moens AL (2012) Tackling endothelial dysfunction by modulating NOS uncoupling: New insights into its pathogenesis and therapeutic possibilities. Am J Physiol Endocrinol Metab 302: E481-E495. doi:10.1152/ajpendo.00540.2011. PubMed: 22167522.
49. Gielis JF, Lin JY, Wingler K, Van Schil PE, Schmidt HH et al. (2011) Pathogenetic role of eNOS uncoupling in cardiopulmonary disorders. Free Radic Biol Med 50: 765-776. doi:10.1016/j.freeradbiomed.2010.12.018. PubMed: 21172428.
50. Bagnost T, Ma L, da Silva RF, Rezakhaniha R, Houdayer C et al. (2010) Cardiovascular effects of arginase inhibition in spontaneously hypertensive rats with fully developed hypertension. Cardiovasc Res 87: 569-577. doi:10.1093/cvr/cvq081. PubMed: 20219858.
51. Cuzzocrea S, Mazzon E, Dugo L, Di Paola R, Caputi AP et al. (2004) Superoxide: A key player in hypertension. FASEB J 18: 94-101. doi: 10.1096/fj.03-0428com. PubMed: 14718390. (Pubitemid 38076469)
52. Salvemini D, Ischiropoulos H, Cuzzocrea S (2003) Roles of nitric oxide and superoxide in inflammation. Methods Mol Biol 225: 291-303. PubMed: 12769497.
53. Hong HJ, Hsiao G, Cheng TH, Yen MH (2001) Supplemention with tetrahydrobiopterin suppresses the development of hypertension in spontaneously hypertensive rats. Hypertension 38: 1044-1048. doi: 10.1161/hy1101.095331. PubMed: 11711495. (Pubitemid 34252803)
54. Cabassi A, Dumont EC, Girouard H, Bouchard JF, Le Jossec M et al. (2001) Effects of chronic N-acetylcysteine treatment on the actions of peroxynitrite on aortic vascular reactivity in hypertensive rats. J Hypertens 19: 1233-1244. doi:10.1097/00004872-200107000-00008. PubMed: 11446713. (Pubitemid 32595279)
55. de las Heras N, Ruiz-Ortega M, Rupérez M, Sanz-Rosa D, Miana M et al. (2006) Role of connective tissue growth factor in vascular and renal damage associated with hypertension in rats. interactions with angiotensin II. J Renin Angiotensin Aldosterone Syst 7: 192-200. doi: 10.3317/jraas.2006.037. PubMed: 17318787. (Pubitemid 46380768)
56. Masuda O, Nakamura Y, Takano T (1996) Antihypertensive peptides are present in aorta after oral administration of sour milk containing these peptides to spontaneously hypertensive rats. J Nutr 126: 3063-3068. PubMed: 9001375. (Pubitemid 27023881)
57. Bejjani S, Wu J (2013) Transport of IRW, an ovotransferrin-derived antihypertensive peptide, in human intestinal epithelial caco-2 cells. J Agric Food Chem 61: 1487-1492. doi:10.1021/jf302904t. PubMed: 23298184.